Standard

Short-term rituximab and methylprednisolone therapy led to restoration of TNFR1 density level on TNFR1+TNFR2+double-positive T cells in rheumatoid arthritis reflecting the effectiveness of treatment. / Alshevskaya, Alina; Lopatnikova, Julia; Zhukova, Julia и др.

в: European Journal of Immunology, Том 51, 08.2021, стр. 232-232.

Результаты исследований: Научные публикации в периодических изданиях › тезисы › Рецензирование

Harvard

Alshevskaya, A, Lopatnikova, J, Zhukova, J, Chumasova, O, Shkaruba, N, Sizikov, A & Sennikov, S 2021, 'Short-term rituximab and methylprednisolone therapy led to restoration of TNFR1 density level on TNFR1+TNFR2+double-positive T cells in rheumatoid arthritis reflecting the effectiveness of treatment', European Journal of Immunology, Том. 51, стр. 232-232.

APA

Alshevskaya, A., Lopatnikova, J., Zhukova, J., Chumasova, O., Shkaruba, N., Sizikov, A., & Sennikov, S. (2021). Short-term rituximab and methylprednisolone therapy led to restoration of TNFR1 density level on TNFR1+TNFR2+double-positive T cells in rheumatoid arthritis reflecting the effectiveness of treatment. European Journal of Immunology, 51, 232-232.

Vancouver

Alshevskaya A, Lopatnikova J, Zhukova J, Chumasova O, Shkaruba N, Sizikov A и др. Short-term rituximab and methylprednisolone therapy led to restoration of TNFR1 density level on TNFR1+TNFR2+double-positive T cells in rheumatoid arthritis reflecting the effectiveness of treatment. European Journal of Immunology. 2021 авг.;51:232-232.

Author

Alshevskaya, Alina ; Lopatnikova, Julia ; Zhukova, Julia и др. / Short-term rituximab and methylprednisolone therapy led to restoration of TNFR1 density level on TNFR1+TNFR2+double-positive T cells in rheumatoid arthritis reflecting the effectiveness of treatment. в: European Journal of Immunology. 2021 ; Том 51. стр. 232-232.

BibTeX

@article{c777f10f47284daf92c7864a03dd15fd,
title = "Short-term rituximab and methylprednisolone therapy led to restoration of TNFR1 density level on TNFR1+TNFR2+double-positive T cells in rheumatoid arthritis reflecting the effectiveness of treatment",
keywords = "Autoimmunity, biomarkers, cytokines and mediators, drugs for immune modulation, immune regulation and therapy, regulatory cells",
author = "Alina Alshevskaya and Julia Lopatnikova and Julia Zhukova and Oksana Chumasova and Nadezhda Shkaruba and Aleksey Sizikov and Sergey Sennikov",
year = "2021",
month = aug,
language = "English",
volume = "51",
pages = "232--232",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "John Wiley & Sons Inc.",

}

RIS

TY - JOUR

T1 - Short-term rituximab and methylprednisolone therapy led to restoration of TNFR1 density level on TNFR1+TNFR2+double-positive T cells in rheumatoid arthritis reflecting the effectiveness of treatment

AU - Alshevskaya, Alina

AU - Lopatnikova, Julia

AU - Zhukova, Julia

AU - Chumasova, Oksana

AU - Shkaruba, Nadezhda

AU - Sizikov, Aleksey

AU - Sennikov, Sergey

PY - 2021/8

Y1 - 2021/8

KW - Autoimmunity

KW - biomarkers

KW - cytokines and mediators

KW - drugs for immune modulation

KW - immune regulation and therapy

KW - regulatory cells

M3 - Meeting Abstract

VL - 51

SP - 232

EP - 232

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

ER -

ID: 35608409